The effect of anamorelin (ONO-7643) on cachexia in cancer patients: Systematic review and meta-analysis of randomized controlled trials.

Shahla RezaeiLivia Costa de OliveiraMatin GhanavatiMahdi ShadnoushMohammad Esmaeil AkbariAtieh AkbariMohammad HadizadehSeyed Hossein ArdehaliHidetaka WakabayashiAla ElhelaliJamal Rahmani

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2023)

Patients with cancer who receive anamorelin as a treatment for cachexia showed a significant increase in body weight, lean body mass, fat mass, IGF-1, and IGFBP-3.

Keyphrases

systematic review
body weight
meta analyses
adipose tissue
randomized controlled trial
bone mineral density
fatty acid
combination therapy
binding protein
body composition
postmenopausal women
smoking cessation